Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease: a Non-inferiority Investigation

NCT05865457 is registered in ClinicalTrials.gov with TRB Chemedica International SA as lead sponsor.

NCT NCT05865457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05865457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease: a Non-inferiority Investigation
Lead sponsor
TRB Chemedica International SA
Phase
Not applicable
Overall status
Recruiting
Start date
September 25, 2025
Completion date
June 30, 2027
Enrollment
80 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease